Search filters

List of works by Giuseppe Procopio

A randomized, multicenter prospective trial assessing long-acting release octreotide pamoate plus tamoxifen as a first line therapy for advanced breast carcinoma

scientific article published in January 2002

Activity of sunitinib in patients with advanced neuroendocrine tumors

scientific article published on 08 December 2008

Adjuvant treatment for renal cell carcinoma: in the long run will we get the same answers?

scientific article published on 07 July 2016

An open-label, single-arm, phase 2 study of the Aurora kinase A inhibitor alisertib in patients with advanced urothelial cancer.

scientific article

Antisecretive and Antitumor Activity of Abiraterone Acetate in Human Adrenocortical Cancer: A Preclinical Study

scientific article published on 14 September 2016

Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours?

scientific article published on 26 August 2006

Are post-docetaxel treatments effective in patients with castration-resistant prostate cancer and performance of 2? A meta-analysis of published trials.

scientific article published on 30 July 2013

Axitinib safety in metastatic renal cell carcinoma: suggestions for daily clinical practice based on case studies

scientific article published on April 2014

Bone metastases affect prognosis but not effectiveness of third-line targeted therapies in patients with metastatic renal cell carcinoma

scientific article

Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis?

scientific article

Butterfly and renal cell cancer: out of chaos comes order

scientific article published on 28 July 2014

Cabozantinib in advanced renal cell carcinoma: a METEOR impact on clinical practice

scientific article published on December 2016

Cabozantinib in the treatment of advanced renal cell carcinoma: design, development, and potential place in the therapy

scientific article

Castration-naive metastatic prostate cancer: reshaping old paradigms

scientific article published on 31 August 2017

CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma

scientific article published on 2 March 2017

Clinical Impact of Pancreatic Metastases from Renal Cell Carcinoma: A Multicenter Retrospective Analysis

scientific article

Clinical Outcomes of Castration-resistant Prostate Cancer Treatments Administered as Third or Fourth Line Following Failure of Docetaxel and Other Second-line Treatment: Results of an Italian Multicentre Study.

scientific article published on 25 October 2014

Clinical Outcomes of Metastatic Poor Prognosis Germ Cell Tumors: Current Perspective From a Referral Center

scientific article

Clinical experience with temsirolimus in the treatment of advanced renal cell carcinoma

scientific article published on June 2015

Clinical outcomes in a contemporary series of "young" patients with castration-resistant prostate cancer who were 60 years and younger

scientific article published on 20 April 2015

Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer

scientific article

Clinical outcomes in patients receiving three lines of targeted therapy for metastatic renal cell carcinoma: results from a large patient cohort

scientific article published on 18 March 2013

Clinical outcomes in patients with metastatic renal cell carcinoma receiving everolimus or temsirolimus after sunitinib

scientific article

Compassionate use of everolimus in a patient with a neuroendocrine tumor: a case report and discussion of the literature.

scientific article published on January 2011

Complete Response After Sequential Sunitinib-Sorafenib Treatment in a Patient With Renal Cell Carcinoma: A Case Report ⬇️

scientific article published on 09 January 2012

Complete responses in advanced renal cell carcinoma: utopia or real chance?

scientific article

Costs of managing adverse events in the treatment of first-line metastatic renal cell carcinoma: bevacizumab in combination with interferon-alpha2a compared with sunitinib

scientific article

Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma?

scientific article published on 11 August 2017

Does F-18 FDG-PET still play a role in metastatic renal cell carcinoma?

scientific article published on 09 January 2017

Dual modulation of MCL-1 and mTOR determines the response to sunitinib

scientific article published on 28 November 2016

Effects of cabozantinib on bone turnover markers in real-world metastatic renal cell carcinoma

scientific article published on 05 November 2020

Efficacy of a chemotherapy combination for the treatment of metastatic neuroendocrine tumours

scientific article

Enzalutamide after chemotherapy in advanced castration-resistant prostate cancer: the Italian Named Patient Program

article

Everolimus and temsirolimus are not the same second-line in metastatic renal cell carcinoma. A systematic review and meta-analysis of literature data

scientific article

Everolimus treatment for neuroendocrine tumors: latest results and clinical potential

scientific article published on 11 January 2017

Evolving treatment landscape in metastatic renal cell carcinoma: where are we now?

scientific article published on 28 January 2016

Experience with sorafenib in the treatment of advanced renal cell carcinoma.

scientific article

Feasibility and activity for sequencing targeted therapies for the treatment of advanced renal cell carcinoma

scientific article published on 02 December 2009

Final results of the European Advanced Renal Cell Carcinoma Sorafenib (EU-ARCCS) expanded-access study: a large open-label study in diverse community settings

scientific article published on 15 February 2011

First line treatment of metastatic renal cell carcinoma: two standards with different toxicity profile

scientific article

From biology to clinical experience: evolution in the knowledge of neuroendocrine tumours

Highlights from the ASCO Genitourinary Symposium 2014: focus on renal and prostate cancer

scientific article published on 27 August 2014

Immune Modulation in Prostate Cancer Patients Treated with Androgen Receptor (AR)-Targeted Therapy

scientific article published on 22 June 2020

Immunotherapy advances in uro-genital malignancies

scientific article

Impact of visceral metastases on outcome to abiraterone after docetaxel in castration-resistant prostate cancer patients.

scientific article published on 5 October 2015

Improved quality of life is the way to longer life

scientific article published on 06 June 2016

In regard to Kagan: “The multidisciplinary clinic” (Int J Radiat Oncol Biol Phys 2005;61:967–968)

scientific article published on 01 September 2005

Incidence and relative risk of hepatic toxicity in patients treated with anti-angiogenic tyrosine kinase inhibitors for malignancy.

scientific article

Is it possible to optimize the use of targeted therapies in the treatment of renal cell carcinoma?

scientific article published on September 2010

Is the new WHO classification of neuroendocrine tumours useful for selecting an appropriate treatment?

scientific article published on 6 June 2005

Is there a role for targeted therapies in the collecting ducts of Bellini carcinoma? Efficacy data from a retrospective analysis of 7 cases ⬇️

scientific article published on January 26, 2012

Lanreotide autogel every 6 weeks compared with Lanreotide microparticles every 3 weeks in patients with well differentiated neuroendocrine tumors: a Phase III Study

scientific article published in November 2006

Lecture: management of chemotherapy-induced febrile neutropenia; guidelines and colony stimulating factors.

scientific article published in November 2011

Low dose of ketoconazole in patients with prostate adenocarcinoma resistant to pharmacological castration

scientific article published on 15 November 2010

Management of advanced genitourinary tumors

scientific article published in March 2012

Management of metastatic castration-resistant prostate cancer: A focus on radium-223: Opinions and suggestions from an expert multidisciplinary panel

scientific article

Medical strategies for treatment of castration resistant prostate cancer (CRPC) docetaxel resistant

scientific article

Metastatic renal cell carcinoma: how to make the best sequencing decision after withdrawal for intolerance to a tyrosine kinase inhibitor.

scientific article published on June 2013

Multimodal treatment of advanced renal cancer in 2017.

scientific article published on 28 September 2017

Natural history of malignant bone disease in renal cancer: final results of an Italian bone metastasis survey

scientific article

Neoadjuvant targeted therapy in renal cell carcinoma

scientific article published on 01 July 2010

Neuroendocrine tumors (NETs)

scientific article published on 01 September 2009

New perspectives in advanced genitourinary malignancies

scientific article published on March 2012

Nivolumab in the treatment of advanced renal cell carcinoma: clinical trial evidence and experience

scientific article

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

scientific article published on 25 September 2015

Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long-term follow-up of the randomized, open-label, phase 3 CheckMate 025 trial

scientific article published on 16 July 2020

Optimizing further treatment choices in short- and long-term responders to first-line therapy for patients with advanced renal cell carcinoma

scientific article published on August 2012

Outcome of Patients with Renal Cell Carcinoma and Multiple Glandular Metastases Treated with Targeted Agents

scientific article published on 17 February 2017

Overall survival for sorafenib plus interleukin-2 compared with sorafenib alone in metastatic renal cell carcinoma (mRCC): final results of the ROSORC trial

scientific article published on 24 September 2013

Patient approach in advanced/metastatic renal cell carcinoma: focus on the elderly population and treatment-related toxicity

scientific article

Post-docetaxel therapy in castration resistant prostate cancer - the forest is growing in the desert

scientific article published on June 2012

Predicting Molecular Models: Where Are We Going?

scientific article published on 09 October 2015

Predictors of health-related quality of life and adjustment to prostate cancer during active surveillance.

scientific article

Predictors of long-term response to abiraterone in patients with metastastic castration-resistant prostate cancer: a retrospective cohort study.

scientific article published on 19 May 2016

Primary resistance to tyrosine kinase inhibitors in patients with advanced renal cell carcinoma: state-of-the-science.

scientific article

Prognostic Role of Pancreatic Metastases From Renal Cell Carcinoma: Results From an Italian Center ⬇️

scientific article published on June 20, 2013

Prognostic factors for survival in patients with metastatic renal cell carcinoma treated with targeted therapies.

scientific article

Prognostic factors in patients receiving third line targeted therapy for metastatic renal cell carcinoma.

scientific article published on 26 November 2014

Prognostic reclassification of patients with intermediate-risk metastatic germ cell tumors: Implications for clinical practice, trial design, and molecular interrogation

scientific article published on 16 May 2015

Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy

scientific article published on 6 January 2015

Pulmonary carcinoid tumours: indolent but not benign

scientific article published in January 2007

REPLY

Rationale and protocol of SOAP: a phase II study to evaluate the efficacy of sorafenib as second-line treatment after pazopanib in patients with advanced renal cell carcinoma

scientific article published on November 2014

Re-treatment with radium-223: first experience from an international, open-label, phase I/II study in patients with castration-resistant prostate cancer and bone metastases

scientific article

Re: Camillo Porta, Emiliano Calvo, Miguel A. Climent, et al. Efficacy and safety of everolimus in elderly patients with metastatic renal cell carcinoma: an exploratory analysis of the outcomes of elderly patients in the RECORD-1 Trial. Eur Urol 2012

scientific article

Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors

scientific article published on 30 December 2019

Real-world cabazitaxel safety: the Italian early-access program in metastatic castration-resistant prostate cancer

scientific article

Response to targeted therapy in urachal adenocarcinoma

scientific article

Risk of recurrence and conditional survival in complete responders treated with TKIs plus or less locoregional therapies for metastatic renal cell carcinoma

scientific article published on 23 March 2016

Safety and Clinical Outcomes of Abiraterone Acetate After Docetaxel in Octogenarians With Metastatic Castration-Resistant Prostate Cancer: Results of the Italian Compassionate Use Named Patient Programme

scientific article published on 6 August 2015

Safety and activity of radium-223 in metastatic castration-resistant prostate cancer: the experience of Istituto Nazionale dei Tumori

scientific article published on 02 March 2020

Safety and activity of sorafenib in different histotypes of advanced renal cell carcinoma

scientific article published in January 2007

Safety and clinical outcomes of patients treated with abiraterone acetate after docetaxel: results of the Italian Named Patient Programme

article

Safety and efficacy of two different doses of capecitabine in the treatment of advanced breast cancer in older women

scientific article published on 14 February 2005

Safety of Abiraterone Acetate in Castration-resistant Prostate Cancer Patients With Concomitant Cardiovascular Risk Factors

scientific article

Safety of long-term exposure to abiraterone acetate in patients with castration-resistant prostate cancer and concomitant cardiovascular risk factors

scientific article published on 5 July 2016

Safety profile and treatment response of everolimus in different solid tumors: an observational study

scientific article published on January 2014

Sequential use of sorafenib and sunitinib in advanced renal-cell carcinoma (RCC): an Italian multicentre retrospective analysis of 189 patient cases

article

Sites of disease as predictors of outcome in metastatic renal cell carcinoma patients treated with first-line sunitinib or sorafenib

scientific article

Sorafenib as first- or second-line therapy in patients with metastatic renal cell carcinoma in a community setting

scientific article

Sorafenib tolerability in elderly patients with advanced renal cell carcinoma: results from a large pooled analysis

scientific article published on 15 January 2013

Sorafenib with interleukin-2 vs sorafenib alone in metastatic renal cell carcinoma: the ROSORC trial

scientific article

Stratification of clear cell renal cell carcinoma by signaling pathway analysis

scientific article

Study design and clinical evidence in mRCC: can we save axitinib as a first-line therapy?

scientific article

Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: the RAINBOW analysis

scientific article

Sunitinib and everolimus in pancreatic neuroendocrine tumors

scientific article published on 01 May 2012

Sunitinib, pazopanib or sorafenib for the treatment of patients with late relapsing metastatic renal cell carcinoma

scientific article published on 18 July 2014

Surgery of locally advanced and metastatic kidney cancer after tyrosine kinase inhibitors therapy: single institute experience.

scientific article published on 7 January 2017

Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors

scientific article published on 4 December 2014

TOKIO rationale and protocol: a phase II study to evaluate the activity and safety of third-line tyrosine kinase inhibitor after 2 tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma

scientific article

Targeted Therapies and Survival: What We Can Learn from Studies in Advanced Renal Cell Carcinoma ⬇️

scientific article published on October 17, 2012

Targeted therapies in advanced renal cell carcinoma: the role of metastatic sites as a prognostic factor

scientific article published on June 2014

Targeted treatments in advanced renal cell carcinoma: focus on axitinib.

scientific article

The 6-year attendance of a multidisciplinary prostate cancer clinic in Italy: incidence of management changes

scientific article published on 8 March 2012

The changes of lipid metabolism in advanced renal cell carcinoma patients treated with everolimus: a new pharmacodynamic marker?

scientific article

Time from Nephrectomy as a Prognostic Factor in Metastatic Renal Cell Carcinoma Patients Receiving Targeted Therapies: Overall Results from a Large Cohort of Patients

Treatment of advanced renal cell carcinoma: recent advances and current role of immunotherapy, surgery, and cryotherapy

scientific article published on 26 October 2016

Treatment of elderly patients with metastatic renal cell carcinoma

scientific article

Treatment-related fatigue with sorafenib, sunitinib and pazopanib in patients with advanced solid tumors: an up-to-date review and meta-analysis of clinical trials.

scientific article published on 07 February 2014

Use of a natural multicomponent mouthwash plus oral hygiene vs oral hygiene alone to prevent everolimus-induced stomatitis: the STOP multicenter, randomized trial

scientific article published on 03 May 2020

Use of tyrosine kinase inhibitors in patients with metastatic kidney cancer receiving haemodialysis: a retrospective Italian survey

scientific article published on 24 February 2012

Paulina is supported by:

About Paulina

Help